Skip to main content
Top

Drugs

Issue 17/2019

Content (9 Articles)

Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?

Massimo Leggio, Augusto Fusco, Claudia Loreti, Giorgio Limongelli, Maria Grazia Bendini, Andrea Mazza, Antonio Frizziero, Daniele Coraci, Luca Padua

Immunotherapy Against Gliomas: is the Breakthrough Near?

Rimas V. Lukas, Derek A. Wainwright, Craig M. Horbinski, Fabio M. Iwamoto, Adam M. Sonabend

Dapagliflozin: A Review in Type 1 Diabetes

Julia Paik, Hannah A. Blair

Tenapanor: First Approval

Anthony Markham

Trifarotene: First Approval

Lesley J. Scott

Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

Donald P. Tashkin, Brian Lipworth, Ralph Brattsand

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images